This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Azathioprine in myasthenia gravis

Authoring team

Azathioprine has been used as a single therapy, or in combination with prednisolone, in the treatment of myasthenia gravis.

The combination of azathioprine and prednisolone has become the most widely used drug treatment for severe myasthenia gravis.

  • a randomised controlled trial comparing prednisolone plus azathioprine with prednisolone alone showed that the prednisolone dose required to maintain remission was lower with combination treatment, over 60% of patients not requiring prednisolone at three years (1)

Note that though azathioprine was the first steroid-sparing agent shown to be effective in myasthenia gravis in a randomised, controlled trial, more recent studies suggest that methotrexate, ciclosporin and mycophenolate mofetil may be suitable alternatives (2)

Reference:

  1. Palace J, Newsom-Davis J, Lecky B (1998). A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology, 50, 1778-83.
  2. Prescriber 2005; 16(6):39-47.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.